Journal of Cystic Fibrosis, 1873-5010

Journal

More filtering options
  1. 2015
  2. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.

    Qvist, T., Gilljam, M., Jönsson, B., Taylor-Robinson, D., Jensen-Fangel, S., Wang, M., Svahn, A., Kötz, K., Hansson, L., Hollsing, A., Hansen, C. R., Finstad, P. L., Pressler, T., Høiby, N. & Katzenstein, T. L., 2015, In : Journal of Cystic Fibrosis. 14, 1, p. 46-52

    Research output: Contribution to journalArticle

  3. Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines.

    Jovic, S., Shikhagaie, M., Mörgelin, M., Jonas Erjefält, Kjellström, S. & Arne Egesten, 2015, In : Journal of Cystic Fibrosis. 14, 4, p. 453-463

    Research output: Contribution to journalArticle

  4. 2012
  5. Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus.

    Magnus Hillman, Leif Eriksson, Mared, L., Helgesson, K. & Mona Landin-Olsson, 2012, In : Journal of Cystic Fibrosis. 11, 2, p. 144-149

    Research output: Contribution to journalArticle

  6. 2011
  7. Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.

    Carlsson, M., Shukla, S., Petersson, A. C., Mårten Segelmark & Thomas Hellmark, 2011, In : Journal of Cystic Fibrosis. 10, p. 265-271

    Research output: Contribution to journalArticle

  8. 2010
  9. Benchmarks for Cystic Fibrosis carrier screening: A European consensus document

    Castellani, C., Macek, M. J., Cassiman, J-J., Duff, A., Massie, J., ten Kate, L. P., Barton, D., Cutting, G., Dallapiccola, B., Dequeker, E., Girodon, E., Grody, W., Highsmith, E. W., Kaariainen, H., Kruip, S., Morris, M., Pignatti, P. F., Pypops, U., Schwarz, M., Soller, M. & 2 othersStuhrman, M. & Cuppens, H., 2010, In : Journal of Cystic Fibrosis. 9, 3, p. 165-178

    Research output: Contribution to journalReview article

  10. 2009
  11. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients

    Fluge, G., Olesen, H. V., Gilljam, M., Meyer, P., Pressler, T., Storrosten, O. T., Karpati, F. & Hjelte, L., 2009, In : Journal of Cystic Fibrosis. 8, 3, p. 198-202

    Research output: Contribution to journalArticle

  12. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods

    Pressler, T., Karpati, F., Granstrom, M., Knudsen, P. K., Lindblad, A., Hjelte, L., Olesen, H. V., Meyer, P. & Hoiby, N., 2009, In : Journal of Cystic Fibrosis. 8, 1, p. 37-42

    Research output: Contribution to journalArticle

  13. 2007
  14. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis.

    Carlsson, M., Leif Eriksson, Pressler, T., Kornfält, R., Mared, L., Meyer, P., Wiik, A., Wieslander, J. & Mårten Segelmark, 2007, In : Journal of Cystic Fibrosis. 6, p. 228-233

    Research output: Contribution to journalArticle